Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

BACKGROUND: Full RNA-Seq is a fundamental research tool for whole transcriptome analysis. However, it is too costly and time consuming to be used in routine clinical practice. We evaluated the transcript quantification agreement between RNA-Seq and a digital multiplexed gene expression platform, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Picornell, A. C., Echavarria, I., Alvarez, E., López-Tarruella, S., Jerez, Y., Hoadley, K., Parker, J. S., del Monte-Millán, M., Ramos-Medina, R., Gayarre, J., Ocaña, I., Cebollero, M., Massarrah, T., Moreno, F., García Saenz, J. A., Gómez Moreno, H., Ballesteros, A., Ruiz Borrego, M., Perou, C. M., Martin, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547580/
https://www.ncbi.nlm.nih.gov/pubmed/31159741
http://dx.doi.org/10.1186/s12864-019-5849-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547580/
https://www.ncbi.nlm.nih.gov/pubmed/31159741
http://dx.doi.org/10.1186/s12864-019-5849-0

Ejemplares similares